PATENT CLAIM ANALYSIS

Application Number: 16004921
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "001100"]

Abstract:
A binding moiety (B) for Carbonic Anhydrase IX (CAIX), the binding moiety comprising: The binding moiety is univalent, bivalent, or multivalent. A targeted therapeutic agent may comprise the binding moiety. The invention also includes a method for treating a disease expressing elevated levels of CAIX by administering the targeted therapeutic agent.

Claim (Index 19):
A targeted therapeutic agent comprising a compound of formula:\n B-L-D\u2003\u2003(I), wherein:\n B is a low molecular weight binding moiety for Carbonic Anhydrase IX (CAIX); \n D is a drug moiety; \n L is a linker that undergoes cleavage in vivo for releasing said drug moiety in an active form;\n wherein said binding moiety is a multivalent binding moiety having two or more ligands for binding to CAIX.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.55
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15431310', '15124058', '14722307', '15477721', '13897911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7611213891361058
- 35 USC 102 Novelty (BERT): 0.5727124976145082
- Combined Prediction Score: 0.7422804999839461
- Mean Citation Score: 324.67310600000013
- Max Citation Score: 537.9128400000002
- Similarity Product: 349.1467553123046

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test